Table 1.
I . BLF501 action/single DXR injection | ||||||||
---|---|---|---|---|---|---|---|---|
Mouse strain |
Group |
Mice/Group |
DXR |
BLF501 25 μg/kg |
Sacrifice 48 h |
Sacrifice 72 h |
BrdU injection |
|
BALB/C |
UNTR |
N = 7 |
- |
- |
- |
N = 7 |
+ |
|
DXR |
N = 14 (7 + 7) |
+ |
- |
N = 7 |
N = 7 |
+ |
||
DXR +BLF501 25 μg/kg |
N = 14 (7 + 7) |
+ |
+ |
N = 7 |
N = 7 |
+ |
||
BLF501 25 μg/kg |
N = 14 (7 + 7) |
- |
+ |
N = 7 |
N = 7 |
+ |
||
Mouse strain |
Group |
Mice/Group |
DXR |
BLF501 25 μg/kg |
Sacrifice 48 h |
Sacrifice 72 h |
BrdU injection |
|
C57 SGLT-1 -/- |
UNTR |
N = 7 |
- |
- |
- |
N = 7 |
+ |
|
|
DXR |
N = 7 |
+ |
- |
- |
N = 7 |
+ |
|
|
DXR +BLF501 25 μg/kg |
N = 7 |
+ |
+ |
- |
N = 7 |
+ |
|
II
. BLF501 action/repeated DXR plus 5-FU injections | ||||||||
Mouse strain |
Group |
Mice/Group |
DXR +5-FU |
BLF501 0.25 μg/kg |
BLF501 2.5 μg/kg |
BLF501 25 μg/kg |
Treatment days |
Sacrifice day |
BALB/C |
UNTR |
N = 7 |
- |
- |
|
|
- |
Day 19 |
DXR + 5FU |
N = 7 |
+ |
- |
|
|
Days 1, 8 and 15 |
||
DXR + 5FU +BLF501 0.25 μg/kg |
N = 7 |
+ |
+ |
|
|
|||
DXR + 5FU +BLF501 2.5 μg/kg |
N = 7 |
+ |
- |
+ |
|
|||
DXR + 5FU +BLF501 25 μg/kg |
N = 7 |
+ |
- |
- |
+ |
|||
BLF501 25 μg/kg |
N = 7 |
- |
- |
- |
+ |
|||
III
. BLF501/DXR interaction | ||||||||
Mouse strain |
Group |
Mice/Group |
DXR |
BLF501 25 μg/kg |
Treatment days |
Sacrifice day |
||
SKH-1 |
UNTR |
N = 8 |
- |
- |
- |
Day 26 | ||
DXR |
N = 8 |
+ |
- |
Days 7, 14 and 21 after cell injection |
||||
DXR +BLF501 25 μg/kg |
N = 8 |
+ |
+ |
|||||
BLF501 | N = 8 | - | + |